OrganiGram Holdings (OGI) Receives a Rating Update from a Top Analyst


OrganiGram Holdings (OGI), the Materials sector company, was revisited by a Wall Street analyst today. Analyst Martin Landry from GMP FirstEnergy rated OrganiGram Holdings (OGI) a Buy, setting a C$10 price target.

Landry has an average return of 46.7% when recommending OrganiGram Holdings.

According to TipRanks.com, Landry is ranked #12 out of 5126 analysts.

OrganiGram Holdings has an analyst consensus of Strong Buy, with a price target consensus of C$10, which is a 38.5% upside from current levels. In a report released today, Canaccord Genuity also reiterated a Buy rating on the stock with a C$8.50 price target.

.

OrganiGram Holdings’ market cap is currently C$887.7M and has a P/E ratio of 44.9. The company has a Price to Book ratio of 4.81.

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. Its products include strains, cannabis oils, and vaporizrs. The company was founded in 2013 and is headquartered in Moncton, Canada.

The company’s shares closed on Tuesday at C$7.22.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts